visiongain Logo.png
Biopharmaceuticals Contract Manufacturing market is projected to grow at a CAGR of 10.0% by 2033: Visiongain
14 juin 2023 09h00 HE | Visiongain Reports Ltd
As per the report by Visiongain, the Biopharmaceuticals Contract Manufacturing Market was valued US$14,140.0 million in 2022 and is projected to grow at a CAGR of 10.0% during the forecast period...
22157.jpg
Pharmaceutical Contract Manufacturing Market Report 2023: Increasing Demand for Biological Therapies
14 juin 2023 04h03 HE | Research and Markets
Dublin, June 14, 2023 (GLOBE NEWSWIRE) -- The Pharmaceutical Contract Manufacturing Market Report 2023-2033 report has been added to ResearchAndMarkets.com's offering. Overall world revenue for...
visiongain Logo.png
Pharmaceutical contract manufacturing market is projected to grow at a CAGR of 10.3% by 2033: Visiongain
12 juin 2023 08h07 HE | Visiongain Reports Ltd
As per the report by Visiongain, the Pharmaceutical Contract Manufacturing Market was valued at US$146.0 billion in 2023 and is projected to grow at a CAGR of 10.3% during the forecast period...
NQR_0010
UPDATE -- Builtmore Contract Manufacturing Celebrates 100,000th Unit Production Milestone With Isuzu for N-Series Gas-Powered Trucks
06 juin 2023 10h06 HE | Builtmore Contract Manufacturing
CHARLOTTE, Mich., June 06, 2023 (GLOBE NEWSWIRE) -- Builtmore Contract Manufacturing™, owned and operated by The Shyft Group, Inc. (NASDAQ: SHYF), the North American leader in specialty vehicle...
NQR_0010
Builtmore Contract Manufacturing Celebrates 100,000th Unit Production Milestone With Isuzu for N-Series Gas-Powered Trucks
05 juin 2023 16h11 HE | Builtmore Contract Manufacturing
CHARLOTTE, Mich., June 05, 2023 (GLOBE NEWSWIRE) -- Builtmore Contract Manufacturing™, owned and operated by The Shyft Group, Inc. (NASDAQ: SHYF), the North American leader in specialty vehicle...
Societal Color Logo and Tagline.png
Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator
23 mai 2023 07h00 HE | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., May 23, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; Nasdaq: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
visiongain Logo.png
Pharmaceutical contract manufacturing market is projected to grow at a CAGR of 10.3% by 2033: Visiongain Reports Ltd
11 mai 2023 11h26 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Pharmaceutical Contract Manufacturing 2023-2033. Forecasts by Service (Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services,...
Avid Logo June 2022.jpg
Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference
10 mai 2023 16h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Societal Color Logo and Tagline.png
Societal CDMO Reports First Quarter 2023 Financial Results
10 mai 2023 16h05 HE | Societal CDMO, Inc.
Recorded Q1 Revenue of $21.5 Million Signed Multiple New Business Agreements with New and Existing Customers Granted FDA Approval for Manufacture of First Commercial Tablet Product Company to Host...
Societal Color Logo and Tagline.png
Societal CDMO to Participate in RBC Capital Markets Global Healthcare Conference
09 mai 2023 16h05 HE | Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., May 09, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...